S3385 stops U.S. government contracts with biotech companies tied to foreign adversaries. Affects federal agencies and contractors using biotech services.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
A bill to prohibit contracting with certain biotechnology providers. is a Senate bill in Congress.
Who this affects: The bill impacts federal agencies, biotech companies, and contractors. Agencies must vet vendors, while foreign-linked biotech firms lose federal business. Contractors need to ensure their suppliers are not on the restricted list.
Why this matters: S3385 is significant for national security, aiming to protect sensitive data from foreign adversaries. It aligns biotech procurement with existing security measures in other sectors, like telecom. The bill also encourages domestic biotech growth by steering federal contracts away from foreign-linked firms.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
